Odyssey Health (ODYY) Change in Accured Expenses (2014 - 2026)
Odyssey Health's (ODYY) quarterly Change in Accured Expenses came in at -$2387.0 in Q2 2026, down 102.88% year-on-year from $82829.0 in Q2 2025, and up 95.77% quarter-over-quarter from -$56392.0 in Q1 2026.
Odyssey Health (ODYY) Change in Accured Expenses (2014 - 2026) Analysis & Trends
Odyssey Health's Change in Accured Expenses history runs 13 years deep, the most recent figure standing at -$2387.0 for Q2 2026.
- On a quarterly basis, Change in Accured Expenses fell 102.88% year-over-year to -$2387.0 in Q2 2026; TTM through Apr 2026 was $37046.0, a 91.03% decrease from a year earlier, with the FY2025 full-year figure at $320838.0, up 30.3% from the prior year.
- Change in Accured Expenses advanced to -$2387.0 in Q2 2026 per ODYY's latest filing, from -$56392.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $463827.0 in Q3 2023 and bottomed at -$77034.0 in Q1 2024.
- The 5-year median for Change in Accured Expenses is $33246.5 (2022), against an average of $61958.2.
- Across the five-year window, Change in Accured Expenses soared 2128.37% in 2023 and plunged 621.42% in 2024, its largest moves.
- Year by year, Change in Accured Expenses stood at $2813.0 in 2022, then surged by 865.66% to $27164.0 in 2023, then soared by 501.88% to $163495.0 in 2024, then plunged by 66.39% to $54953.0 in 2025, then slumped by 104.34% to -$2387.0 in 2026.
- Per Business Quant, the three latest ODYY Change in Accured Expenses figures stand at -$2387.0 (Q2 2026), -$56392.0 (Q1 2026), and $54953.0 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | -2,387.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -2,387.00 |
| Apr 30, 2026 | -2,387.00 |
| Jan 31, 2026 | -56,392.00 |
| Jan 31, 2026 | -56,392.00 |
| Oct 31, 2025 | 54,953.00 |
| Oct 31, 2025 | 54,953.00 |
| Jul 31, 2025 | 40,872.00 |
| Jul 31, 2025 | 40,872.00 |
| Apr 30, 2025 | 82,829.00 |
| Apr 30, 2025 | 82,829.00 |
| Jan 31, 2025 | 33,642.00 |
| Jan 31, 2025 | 33,642.00 |
| Oct 31, 2024 | 163,495.00 |
| Oct 31, 2024 | 163,495.00 |
| Jul 31, 2024 | 132,823.00 |
| Jul 31, 2024 | 132,823.00 |
| Apr 30, 2024 | 163,285.00 |
| Apr 30, 2024 | 163,285.00 |
| Jan 31, 2024 | -77,034.00 |
| Jan 31, 2024 | -77,034.00 |